Oncology - care of the oncology patient admitted to PICU - blood testing and blood product transfusion
This document is only valid for the day on which it is accessed. Please read our disclaimer.
- Patients should receive irradiated and leukocyte depleted blood products
- Patients post stem cell/bone marrow transplant should receive irradiated, leukocyte depleted and CMV tested negative blood products (unless the patient is known CMV +ve).
- Post chemotherapy patients will generally become cytopenic day 8 to 14.
Need to take into account patient age and clinical state.
General guidelines are:
- transfuse if haemaglobin below 80g/L or patient symptomatic
- transfuse platelets if less than 10 x 109 or symptomatic, or febrile
- post BMT platelets transfuse less than 20 x 109 or symptomatic
- pre procedure or patient bleeding transfuse to get platelet count above 50 x 109/L
- Pre LP/BMA transfuse to platelets 100 x 109
- FFP/Cryo/albumin 20%/IVIG transfuse as per PICU guidelines
- as per PICU protocol
- newly diagnosed or relapsed pts - please see tumour lysis protocol
- if pt on G-CSF (Filgrastim) ensure FBC with differential done daily
Post Stem Cell or Bone Marrow Transplant
- daily CBC, urea and creatinine
- twice weekly coagulation tests
- twice weekly CMV(tuesday and thursday)
- monthly EBV, MRSA and VRE screen
- If patient on mycofenalate, tacrolimus or cyclosporine do levels and proceed to give dose. Subsequent doses will be changed if necessary.
- mycofenalate, tacrolimus and cyclosporin levels weekly
Did you find this information helpful?
- Date last published: 10 June 2016
- Document type: Clinical Guideline
- Services responsible: Paediatric Intensive Care Unit
- Owner: Fiona Miles
- Editor: John Beca
- Review frequency: 2 years
SIGN UP TO RECEIVE GUIDELINE UPDATES
Subscribe below if you want us to let you know about new or updated guidelines